FDA, DHS Reunite to Address Cybersecurity Vulnerabilities in Healthcare Devices

The Food and Drug Administration and Department of Homeland Security have partnered to resolve cybersecurity issues in medical systems to maintain patient safety.

The FDA said Tuesday its Center for Devices and Radiological Health and the DHS’ Office of Cybersecurity and Communications will coordinate with each other and initiate discussions with medical device manufacturers and researchers about cyber vulnerabilities and threats to health care technologies.

“As innovation in medical devices advances and more devices are connected to hospital networks or to other devices, ensuring that devices are adequately protected against cyber intrusions is paramount to protecting patients,” said FDA Commissioner Scott Gottlieb.

He added that the partnership will allow the two agencies to support the health care sector in responding to identified system flaws.

The agreement is a continuation to FDA and DHS’ partnership in identifying and resolving vulnerabilities in medical devices.

Check Also

Cybersecurity Strategy

Updated CISA Federal Cybersecurity Strategy Directs Improved CDM Scores Through FY 2021

The Cybersecurity and Infrastructure Security Agency (CISA) has released an update to its action plan for strengthening federal cybersecurity in fiscal years 2020 through 2021. The initiative was led by Matthew Travis, the deputy director of CISA. CISA also cited evolving threat landscapes and limitations in cloud, network and encryption capabilities as challenges.